Flamma Spa

Chignolo D'Isola (BG), 
Italy
http://www.flammagroup.com
  • Booth: 2344

FLAMMA is a specialty pharmaceutical chemical manufacturer based in the Bergamo area (near Milan in Northern Italy) that was established in 1950. FLAMMA is a company specialized in the cGMP manufacture of APIs, NCEs, RSMs, & advanced intermediates for the pharmaceutical industry. Flamma has particular expertise in high value chiral materials specifically amino acid related materials. FLAMMA has three manufacturing facilities all with R&D labs. Both Italian locations are FDA inspected cGMP facilities. Flamma’s Dalian, China facilities has both cGMP & non-cGMP production capabilities. We leverage our self-owned, self-managed facilities in China to support Italy and customers. Flamma can be of assistance for early stage pre-clinical development of small molecules as well as for large-scale commercial manufacturing. With a total capacity of 450 m3 & over 400 employees, see why Flamma should be your next contract manufacturer. FLAMMA- WHERE IT MATTERS MOST. 2017 CMO LEADERSHIP AWARD winner

Brands: MelaPure, CarnoPure, Ultra-Pure Moc-valine, FLAMMA, http://cen.acs.org/articles/93/i42/Italian-Fine-Chemicals-Maker-Flamma.html


 Press Releases

  • CHIGNOLO D'ISOLA, BERGAMO, ITALY – March 28, 2017 – Flamma SpA (“Flamma”), a preeminent Contact Manufacturing Organization (CMO) that develops, manufactures, and commercializes small molecule active pharmaceutical ingredients (APIs) for the pharmaceutical industry, is delighted to announce that it has been awarded six CMO Leadership Awards in the areas of quality, reliability, capabilities, expertise, development and compatibility.

    Dr. Gian Paolo Negrisoli, President and CEO of Flamma remarked, “Flamma is thankful to be recognized for the second straight year by those in the industry by receiving the maximum number of six CMO Leadership Awards for 2017. Being 100% family owned and run since 1950 brings a passion that is missing in our field. We are looking forward to the future and know that when it matters most, pharma and biotech companies are continuing to turn to Flamma!”

    Life Science Leader started the CMO Leadership Awards six years ago. Industry Standard Research (ISR) conducts the research for Life Science Leader’s CMO Awards. ISR’s stringent screening processes and the high caliber of qualification required to participate in our contract manufacturing benchmarking research means that REAL customers provide experiential feedback on their involvement with contract suppliers over the past 18 months.

    Customers and industry professionals rated Flamma as a top performer within the overall (combined Big and Small Pharma) category for quality, reliability, capabilities, expertise, development and compatibility.

    “Flamma continues to grow its customer base thanks to the hard work of our entire team. Recent improvements at all of our facilities continue to show the commitment by management to serve customers,” noted Kenneth Drew, Ph.D., Sr. Director North America Sales and Business Development. “One of the things that differentiates Flamma from others is our long term vision with customers. We do not have short term views nor do we have to answer to the demands from shareholders, private equity groups, or venture capital firms.”

    Flamma proudly accepted the awards at the CMO Leadership Awards Ceremony and Reception held on March 22, 2017 at the W Hotel in New York City.

    Contact Flamma

    Kenneth Drew, Ph.D., Sr. Director, North America Sales and Business Development

    1-617-515-0975

    ken.drew@flammagroup.com

    About Flamma:

    FLAMMA is a 100% family owned & run, privately held specialty Contract Manufacturer (CMO) based in Bergamo (near Milan), Italy founded in 1950. Flamma is a preeminent cGMP manufacturer of APIs including high value functional amino acids and chiral materials.

    FLAMMA has 3 manufacturing facilities (each with their own R&D departments), 400 employees, and 450 m3 of capacity giving FLAMMA flexibility to serve customers. Both Italian locations are cGMP & regularly inspected by the FDA & AIFA. Flamma leverages their self-owned, self-managed cGMP facilities in China to deliver results. Flamma offers cost-effective services to customers looking for a trusted partner in Europe and China.

    FLAMMA - Where It Matters Most

     For more information, please visit www.flammagroup.com